Estimation of global nanomedicine market: status, segment analysis, dynamics, competition and prospects

Authors

DOI:

https://doi.org/10.15587/2706-5448.2024.299271

Keywords:

nanomedicine, world market, market status, segment analysis, market dynamics, competition, market prospects

Abstract

The object of research is the state, segment analysis, dynamics, competition and prospects of the global nanomedicine market. The methods of searching and analyzing literary data, summarizing, systematizing and visualizing data using diagrams are used.

In 2020, health care was identified as the most commercial sector of the modern nanotechnology market with a share of capital investments of 19.5 %. The leadership of this field is due to the increased use of nanotechnology in the development of nanodiagnostics, nanosurgical robots, applications for cell repair, nanobiosensors, visualization and targeted drug delivery.

According to the analysis of the nanomedicine market, the structure of nanomaterials in 2022 was dominated by the segment of nanoparticles with a share of capital investments of 74 %, by the scope of application – the segment of drug delivery (25.1 %), by the method of action – the segment of treatment (23.8 %), by the scope of action – the segment of clinical oncology (32.4 %), by geographical regions – the segment of the North America region (26.4 %).

The main factors of the dynamics of the global market of nanomedicine are determined. This is an increase in the prevalence of chronic diseases; modern achievements in the development of nanomaterials and nanotechnologies; limited possibilities of the nanomedicine market; significant costs for scientific research, development of drugs and devices. As well as concerns about the safety of using nanomaterials and nanotechnologies; the potential toxicity and long-term effects of nanoparticle exposure on human health are under investigation.

Prospects for further scientific research in the field of nanomedicine are determined. This is the deepening of collaboration and cooperation of the world's scientists and manufacturers of medical nanoproducts; development of new technologies for obtaining nanoparticles, especially composites of organic and inorganic origin; creation of medicinal forms for external, internal and inhalation use. As well as the search for new nanopreparations and studying the mechanisms of their therapeutic action; research of toxicological, kinetic and dynamic effects of nanomaterials; establishment of all aspects of the interaction of nanostructures with the body and the environment. And a significant increase in the volume of scientific research on nanomedicine and nanophysiotherapy; an increase in government funding for research and development, which will open up attractive opportunities for the expansion of the global nanomedicine market.

Author Biographies

Victor Malyshev, Private Institution of Higher Education «International European University»

Doctor of Technical Science, Professor

Department of Fundamental and Medical and Preventive Disciplines

 

Angelina Gab, Private Institution of Higher Education «International European University»

PhD, Associated Professor

Department of Fundamental and Medical and Preventive Disciplines

Viktoriia Kovalenko, Private Institution of Higher Education «International European University»

PhD, Associated Professor

Department of Fundamental and Medical and Preventive Disciplines

Oleksandr Pryshedko, Private Institution of Higher Education «International European University»

Department of Financial and Economic Support

Dmytro Shakhnin, Private Institution of Higher Education «International European University»

PhD, Associated Professor

Department of Fundamental and Medical and Preventive Disciplines

References

  1. European Technology Platform on NanoMedicine: Nanotechnology for Health. Available at: ftp://ftp.cordis.europa.eu/pub/nanotechnology/docs/nanomedicine_visionpaper.pdf
  2. Glossary. Available at: http://www.nanomedicine.com/NMI/Glossary.htm
  3. Nanomedicine, Volume I: Basic Capabilities. Available at: http://www.nanomedicine.com/NMI/1.2.2.htm#
  4. Hardashuk, T. V. (2013). Nanotekhnolohii ta pidvalyny medytsyny. Intehratyvna antropolohiia, 2, 15–20. Available at: http://nbuv.gov.ua/UJRN/Ia_2013_2_4
  5. Baker, C., Pradhan, A., Pakstis, L., Pochan, Darrin, J., Shah, S. I. (2005). Synthesis and Antibacterial Properties of Silver Nanoparticles. Journal of Nanoscience and Nanotechnology, 5 (2), 244–249. doi: https://doi.org/10.1166/jnn.2005.034
  6. Martsenyuk, V. P., Melenchuk, I. B. (2012). Principle of using nanotechnologies in pharmacy and medicine. Medical Informatics and Engineering, 3. doi: https://doi.org/10.11603/mie.1996-1960.2012.3.196
  7. Pryskoka, A. O., Chekman, I. S. (2010). Nanotechnologies in development of drug delivery systems. Ukrainskyi medychnyi chasopys, 1 (75), 14–18. Available at: www.umj.com.ua/uk/publikatsia-2951-nanotexnologii-u-rozrobci-sistem-dostavki-likarskix-zasobiv
  8. Brubaker, I., Bilan, O., Marchenko-Tolsta, K. (2020). Modern approaches to development of nano-systems for drug delivery. World Science, 1 (6 (58), 32–37. doi: https://doi.org/10.31435/rsglobal_ws/30062020/7102
  9. Brubaker, I. O., Bilan, O. A., Marchenko-Tolsta, K. S. (2020). Innovations in nanomedicine and nanopharmacy. World Science, 7 (59). doi: https://doi.org/10.31435/rsglobal_ws/30092020/7164
  10. Kim, B. Y. S., Rutka, J. T., Chan, W. C. W. (2010). Nanomedicine. New England Journal of Medicine, 363 (25), 2434–2443. doi: https://doi.org/10.1056/nejmra0912273
  11. Joseph, T., Kar Mahapatra, D., Esmaeili, A., Piszczyk, Ł., Hasanin, M., Kattali, M., Haponiuk, J., Thomas, S. (2023). Nanoparticles: Taking a Unique Position in Medicine. Nanomaterials, 13 (3), 574–632. doi: https://doi.org/10.3390/nano13030574
  12. Jain, K. K. (2008). The Handbook of Nanomedicine. Basel. Switzerland: Humana Press, 404. doi: https://doi.org/10.1007/978-1-60327-319-0
  13. Pylypchuk, L. L., Blyzniuk, V. M. (2020). Nanomaterialy v khimii ta farmatsii. Kherson: Oldy-plius, 168.
  14. Zaiachuk, D. M. (2022). Nanotekhnolohii v medytsyni ta biolohii. Lviv: Lvivska politekhnika, 304.
  15. Boichenko, V., Malyshev, V., Voitsekhivskyi, M., Gab, A., Lukashenko, T. (2023). Nanotechnologies in chemistry: increasing the qualifications of teachers, elective courses, methodological ideas, assignments and content formation. Continuing Professional Education: Theory and Practice, 77 (4), 117–135. doi: https://doi.org/10.28925/1609-8595.2023.4.10
  16. Malyshev, V., Kushchevska, N., Korotieieva, A., Bruskova, D.-M., Lukashenko, T., Zalubovskiy, M. (2018). Investigation of state, trends and structure of the world market of nanopowders. Technology Audit and Production Reserves, 2 (4 (46)), 34–42. doi: https://doi.org/10.15587/2312-8372.2019.167234
  17. Korotieieva, A. V., Kushchevska, N. F., Malyshev, V. V. (2015). Doslidzhennia rynku nanoporoshkiv: prohnoz obsiahu vyrobnytstva ta rozvytku, struktura rynku, tsinovyi analiz. Marketynh v Ukraini, 5 (92), 29–33. Available at: http://nbuv.gov.ua/UJRN/Mvu_2015_5_7
  18. Malyshev, V., Kushchevska, N., Korotieieva, A., Bruskova, D.-M., Zalubovskiy, M., Lukashenko, T. (2018). Analysis and systematization of marketing studies data of the Ukrainian nanopowder market and formation of the program for its development. Technology Audit and Production Reserves, 3 (4 (47)), 28–34. doi: https://doi.org/10.15587/2312-8372.2019.172152
  19. Nanotechnology Market Size, Share & COVID-19 Impact Analysis. Available at: https://www.fortunebusinessinsights.com/amp/nanotechnology-market-108466
  20. Global Nanomedicine Market by Molecule Type. Available at: https://market.us/report/nanomedicine-market/
  21. Nanomedicine Market. Available at: https://www.precedenceresearch.com/nanomedicine-market
  22. Global Nanomedicine Market Size. Available at: https://www.skyquestt.com/report/nanomedicine-market
  23. Nanomedicine Market to Reach $393.04 Bn, Globally, by 2030 at 9.2 % CAGR (2022). Available at: https://medium.com/@ashbachchan41/nanomedicine-market-to-reach-393-04-bn-globally-by-2030-at-9-2-cagr-870ba4be691e
  24. Kad, A., Pundir, A., Arya, S. K., Bhardwaj, N., Khatri, M. (2020). An Elucidative Review to Analytically Sieve the Viability of Nanomedicine Market. Journal of Pharmaceutical Innovation, 17 (1), 249–265. doi: https://doi.org/10.1007/s12247-020-09495-5
  25. Nanomedicine Market. Available at: https://www.gminsights.com/industry-analysis/nanomedicine-market
  26. Rösslein, M., Liptrott, N. J., Owen, A., Boisseau, P., Wick, P., Herrmann, I. K. (2017). Sound understanding of environmental, health and safety, clinical, and market aspects is imperative to clinical translation of nanomedicines. Nanotoxicology, 11 (2), 147–149. doi: https://doi.org/10.1080/17435390.2017.1279361
  27. Korpan, M. I., Chekman, I. S., Zahorodnyi, M. I., Svintsitskyi, I. A., Fialka-Mozer, V. (2009). Nanonauka, nanotekhnolohii, nanomedytsyna: stan naukovo-praktychnykh doslidzhen. Likarska sprava, 5-6, 3–8. Available at: http://ir.librarynmu.com/handle/123456789/4034
  28. Ulberh, Z. R., Chekman, I. S. (2013). Nanopharmacology: Interdisciplinary Aspect of Scientific Research. Ukrainskyi zhurnal suchasnykh problem toksykolohii, 1-2, 32–37. Available at: http://protox.medved.kiev.ua/index.php/en/issues/2013/1-2/item/55-nanopharmacology-interdisciplinary-aspect-of-scientific-research
  29. Baun, A., Hartmann, N. B., Grieger, K., Kusk, K. O. (2008). Ecotoxicity of engineered nanoparticles to aquatic invertebrates: a brief review and recommendations for future toxicity testing. Ecotoxicology, 17 (5), 387–395. doi: https://doi.org/10.1007/s10646-008-0208-y
  30. Elder, J. B., Liu, C. Y., Apuzzo, M. L. J. (2008). Neurosurgery in the realm of 10(-9), Part 2: application of nanotechnology neurosurgery – present and future. Neusurgery, 62 (2), 269–285. doi: https://doi.org/10.1227/01.neu.0000315995.73269.c3
  31. Medina, C., Santos‐Martinez, M. J., Radomski, A., Corrigan, O. I., Radomski, M. W. (2007). Nanoparticles: pharmacological and toxicological significance. British Journal of Pharmacology, 150 (5), 552–558. doi: https://doi.org/10.1038/sj.bjp.0707130
  32. Xia, T., Kovochich, M., Brant, J., Hotze, M., Sempf, J., Oberley, T. et al. (2006). Comparison of the Abilities of Ambient and Manufactured Nanoparticles to Induce Cellular Toxicity According to an Oxidative Stress Paradigm. Nano Letters, 6 (8), 1794–1807. doi: https://doi.org/10.1021/nl061025k
  33. Yang, W., Peters, J. I., Williams, R. O. (2008). Inhaled nanoparticles – A current review. International Journal of Pharmaceutics, 356 (1-2), 239–247. doi: https://doi.org/10.1016/j.ijpharm.2008.02.011
  34. Svintsitskyi, I. A. (2009). Nanotechnology and nanomedicine: ethical and social issues. Ukrainskyi naukovo-medychnyi molodizhnyi zhurnal, 4, 12–16. Available at: https://www.researchgate.net/publication/304155977_Nanotehnologii_i_nanomedicina_eticni_ta_socialni_aspekti_Nanotechnology_and_nanomedicine_ethical_and_social_issues
  35. Best, R., Khushf, G. (2006). The Social Conditions for Nanomedicine: Disruption, Systems, and Lock-In. Journal of Law, Medicine & Ethics, 34 (4), 733–740. doi: https://doi.org/10.1111/j.1748-720x.2006.00093.x
  36. Godman, M. (2008). But is it Unique to Nanotechnology? Science and Engineering Ethics, 14 (3), 391–403. doi: https://doi.org/10.1007/s11948-008-9052-y
  37. Mills, K., Fleddermann, C. (2005). Getting the best from nanotechnology: Approaching social and ethical implications openly and proactively. IEEE Technology and Society Magazine, 24 (4), 18–26. doi: https://doi.org/10.1109/mtas.2005.1563498
  38. Susanne, C., Casado, M., Buxo, M. J. (2005). What challenges offers nanotechnology to bioethics? Revista de Derecho y Genoma Humano, 22, 27–45. Available at: https://www.researchgate.net/publication/7385138_What_challenges_offers_nanotechnology_to_bioethics
Estimation of global nanomedicine market: status, segment analysis, dynamics, competition and prospects

Downloads

Published

2024-02-29

How to Cite

Malyshev, V., Gab, A., Kovalenko, V., Pryshedko, O., & Shakhnin, D. (2024). Estimation of global nanomedicine market: status, segment analysis, dynamics, competition and prospects. Technology Audit and Production Reserves, 1(4(75), 48–59. https://doi.org/10.15587/2706-5448.2024.299271

Issue

Vol. 1 No. 4(75) (2024): Economics of enterprises. Macroeconomics

Section

Development of Productive Forces and Regional Economy

License

Copyright (c) 2024 Victor Malyshev, Angelina Gab, Viktoria Kovalenko, Oleksandr Pryshedko, Dmytro Shakhnin

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The consolidation and conditions for the transfer of copyright (identification of authorship) is carried out in the License Agreement. In particular, the authors reserve the right to the authorship of their manuscript and transfer the first publication of this work to the journal under the terms of the Creative Commons CC BY license. At the same time, they have the right to conclude on their own additional agreements concerning the non-exclusive distribution of the work in the form in which it was published by this journal, but provided that the link to the first publication of the article in this journal is preserved.